Search

everythinglearnresearchcommunity

for

Search:↓

Removing the outer skin layer increases drug absorption and offers non-invasive treatment options, with some methods allowing for quick skin recovery.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

PCOS requires personalized treatment to improve life quality and reduce health risks.

Hashimoto thyroiditis is an autoimmune disease that can lead to an underactive thyroid and is treated with medication and sometimes diet changes or surgery.

Ageratum Conyzoides, when taken orally, can effectively reduce hair loss and improve hair growth.

Oral tranexamic acid is a safe and effective treatment for melasma.

PCOS is a complex condition that affects women's hormonal balance and metabolism, requiring lifestyle changes and medical management.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Ageratum conyzoides L. extract may effectively and safely treat hair loss.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Forensic hair analysis for drugs is now more reliable and accurate.

Modern hair restoration techniques can effectively treat hair loss and provide natural-looking results.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

Bariatric surgery patients need careful before and after surgery care for safety and long-term health.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Some drugs can cause serious side effects like heart issues and nervous system problems, but certain drugs for Parkinson's and overactive bladder may be safer, though they still have some common side effects.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.